Delcold 500 is a multi-ingredient pharmaceutical formulation engineered for efficacy and stability in pharmaceutical manufacturing. The combination of Paracetamol, a potent analgesic and antipyretic; Phenylephrine Hydrochloride, a nasal decongestant; Caffeine, a central nervous system stimulant; and Diphenhydramine Hydrochloride, an antihistamine, creates a synergistic profile for addressing complex symptomatology. The formulation employs a direct compression technique to ensure uniform distribution of active ingredients, with excipients selected for compatibility, stability, and bioavailability. The tablet’s disintegration and dissolution profiles are optimized to ensure rapid onset of action, while maintaining the integrity of the active pharmaceutical ingredients (APIs) during storage. The formulation is designed to meet stringent pharmaceutical standards for tablet hardness, weight variation, and content uniformity, ensuring consistent performance across batches.
Manufacturing Capability
Delcold 500 is manufactured using state-of-the-art pharmaceutical infrastructure, including high-speed tablet compression lines, automated blending systems, and advanced coating facilities. The manufacturing process adheres to Good Manufacturing Practice (GMP) guidelines, ensuring compliance with international quality standards. The facility is equipped with sterile processing capabilities for critical components, including aseptic filling lines for blister packaging. Production scalability is achieved through modular manufacturing units, enabling seamless transitions from small-scale trials to large-volume commercial production. Quality systems are integrated throughout the manufacturing lifecycle, with real-time monitoring of critical process parameters such as temperature, humidity, and particle size distribution. The facility also supports batch traceability, ensuring full compliance with regulatory requirements for pharmaceutical supply chains.
Available Strengths and Packaging
Delcold 500 is available in a single strength: Paracetamol 500mg + Phenylephrine Hydrochloride 5mg + Caffeine 30mg + Diphenhydramine Hydrochloride 25mg. The product is packaged in 10x10 blister packs, designed for secure storage, tamper-evidence, and efficient distribution. The blister packaging ensures product stability during transit and extends shelf life while maintaining compliance with pharmaceutical packaging regulations.
Contract Manufacturing / Third Party Manufacturing
Delwis Healthcare offers comprehensive contract manufacturing and third-party manufacturing services tailored to pharmaceutical buyers. Our facility supports private label manufacturing, enabling clients to produce branded formulations under their own trademarks. We provide end-to-end solutions, from API sourcing and formulation development to packaging and regulatory documentation. Our capabilities include customization of dosage forms, excipient selection, and compliance with regional regulatory requirements. For global markets, we facilitate export-ready manufacturing, ensuring adherence to local guidelines while maintaining consistency in quality and safety standards.
Quality Assurance
Quality assurance for Delcold 500 is enforced through rigorous analytical validation, batch testing, and continuous process monitoring. Each production batch undergoes testing for API content, dissolution rate, and physical properties such as hardness and disintegration time. Advanced analytical techniques, including High-Performance Liquid Chromatography (HPLC) and UV spectrophotometry, are employed to ensure potency, purity, and absence of contaminants. The quality control system is ISO 9001-certified, with dedicated laboratories for microbial testing, heavy metal analysis, and stability studies. All processes are validated to meet International Council for Harmonisation (ICH) guidelines, ensuring compliance with global pharmaceutical quality standards.
Regulatory Compliance
Delcold 500 complies with Good Manufacturing Practice (GMP) standards set by the FDA, EMA, and WHO. The manufacturing process adheres to ISO 17025 accreditation for testing laboratories and ISO 9001 for quality management systems. The product meets specifications outlined in USP, EP, and BP pharmacopoeias, ensuring global market acceptance. Regulatory documentation, including batch certificates of analysis (CoA), stability data, and regulatory filings, is provided to support compliance with regional and international requirements. Our facility is registered with key regulatory authorities, enabling seamless export and distribution across markets.
Global Supply Capability
Delwis Healthcare specializes in global supply chain solutions, with a robust network for exporting pharmaceutical products to over 50 countries. Our bulk supply capacity is supported by automated warehouse systems, ensuring efficient handling of large orders. The company maintains strategic partnerships with logistics providers to guarantee timely delivery and compliance with import regulations. Supply chain reliability is ensured through real-time tracking, inventory management systems, and contingency planning for disruptions. Bulk supply options include flexible packaging solutions and customized shipping arrangements to meet the demands of pharmaceutical distributors and exporters.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners choose Delwis Healthcare for our commitment to quality, compliance, and scalability. Our expertise in multi-ingredient formulation, combined with GMP-certified manufacturing, ensures consistent product performance. The company’s global supply capabilities and regulatory expertise enable seamless market entry, while our responsive customer support and transparent communication foster long-term partnerships. With a focus on innovation and reliability, Delwis Healthcare delivers value-driven solutions tailored to the needs of the pharmaceutical industry.
Bulk Supply Inquiry
Delwis Healthcare offers bulk supply options for Delcold 500. For inquiries regarding large-scale procurement, please contact our sales team at info@delwishealthcare.com.
FAQs
What is the minimum order quantity for bulk supply of Delcold 500?
The minimum order quantity is flexible and can be customized based on your requirements.
Does Delwis Healthcare comply with WHO guidelines for pharmaceutical manufacturing?
Yes, our facility adheres to WHO GMP guidelines and maintains compliance with international regulatory standards.
Can Delcold 500 be manufactured in different dosage forms?
While Delcold 500 is currently available as a tablet, we offer formulation customization for alternative dosage forms upon request.
What certifications does Delwis Healthcare hold for quality management?
Our facility is ISO 9001 and ISO 17025 certified, ensuring adherence to global quality and testing standards.
Is Delcold 500 suitable for export to international markets?
Yes, the product meets regulatory requirements for export to over 50 countries, with full documentation for compliance.
How does Delwis Healthcare ensure product stability during storage?
The blister packaging and controlled manufacturing environment ensure stability, with stability data provided for shelf-life validation.
Can Delwis Healthcare provide private label manufacturing services?
Yes, we offer private label manufacturing solutions to help clients brand and distribute their products globally.
What is the lead time for bulk orders of Delcold 500?
Lead times vary based on order volume and production schedule. Please contact our team for a tailored timeline.
Does Delwis Healthcare support contract manufacturing for third-party clients?
Yes, we provide end-to-end contract manufacturing services, including formulation development and regulatory support.
How can I request a sample of Delcold 500 for evaluation?
Samples are available upon request. Contact our sales team at **info@delwishealthcare.com** for details.
